In 2013, Autobio launched AutoLumo A2000 — China's first fully automated chemiluminescence immunoassay analyzer with 200 tests/hour random-access CLIA microparticle platform, breaking the monopoly of international giants and setting new industry benchmarks.
Autobio has established seven major biotechnology platforms, developed twelve core technologies, and built a "one-stop" closed-loop biomaterials development platform. It leads by a significant margin in the supply of core raw materials such as antigens, antibodies, enzymes, and fluorescently modified dNTPs, greatly enhancing the stability and accuracy of diagnostic products and solidifying the company's core competitive advantage.
On October 18, the Global MicroLabTalk Forum 2025, jointly hosted by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and Autobio, was grandly convened.
On July 27, the 4th Biominds Talks Latin American Forum on Immunoassay Medicine was successfully held in Mexico City.
On July 16th, Autobio successfully held the 5th Biominds Talks Asia Clinical Laboratory Testing Conference, where nearly 100 top experts and scholars in the industry gathered to have in-depth discussions and exchanges on the future development of testing technology.
Global LabTalk Forum 2025 was jointly organized by Autobio and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), attracted nearly 300 experts and scholars from more than 20 countries and regions around the world.
Deepening International Cooperation and Building a New Ecology of Global Cooperation
From March 25th to 27th, partners from dozens of countries and regions around the world gathered in Zhengzhou. The agenda included a site visit to the company's research and development, intelligent production, entering China's first medical testing museum, and participation in the Partner Forum meeting.
AutoChem B2000 series stood out among many entries to win the German iF Design Award 2025
Autobio Human Immunodeficiency Virus Antibody and Antigen (p24) Combined Test Kit (Magnetic Particle Chemiluminescence) and Hepatitis C Virus Test Kit (Magnetic Particle Chemiluminescence) have been awarded CE IVDR Class D certificates
The rapid advancements in artificial intelligence are permeating various sectors at an extraordinary pace, including laboratory medicine.Autobio has successfully implemented the DeepSeek localisation, officially introducing the DeepSeek-R1 model, and has completed the transformation and upgrading of the core functions of the 'Autobio AI Clinical Decision Aid System'.
Autobio recently held the 9th International Distributor Forum in Dubai on 4th February, with the theme of the conference being 'Closer, Together, Brighter'. The event gathered almost 200 partners and associates from around the world, who came together to discuss innovative ideas.
Address: NO.87 Jingbei Yi Rd, National Eco＆Tech Zone, Zhengzhou, China
Email: info@autobio-diagnostics.com Tel: +86-371-6200-7036
Autobio Copyright Reserved for ICP 18006568. All Rights Reserved.
Select Market or Language
